Cargando…

Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo

Background: Docetaxel and doxorubicin combination has been widely used in anaplastic thyroid cancer/ATC treatment but often results in serious adverse effects and drug resistance. Resveratrol effectively inhibits ATC cell proliferation in vitro without affecting the corresponding normal cells, while...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Le, Lin, Xiao-Min, Nie, Jun-Hua, Ye, Hai-Shan, Liu, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806457/ https://www.ncbi.nlm.nih.gov/pubmed/33457193 http://dx.doi.org/10.7150/ntno.53844

Ejemplares similares

Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations
por: Lu, Meng-Di, et al.
Publicado: (2022)

Biological implications of PTEN upregulation and altered sodium/iodide symporter intracellular distribution in resveratrol-suppressed anaplastic thyroid cancer cells
por: Xiong, Le, et al.
Publicado: (2020)

Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells
por: Li, Yi-Tian, et al.
Publicado: (2018)

Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
por: Garg, Manoj, et al.
Publicado: (2017)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
por: Su, Xi, et al.
Publicado: (2020)

Complete Remission of Anaplastic Thyroid Carcinoma after Concomitant Treatment with Docetaxel and Radiotherapy
por: Abe, Ichiro, et al.
Publicado: (2015)

Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases
por: Seto, Akira, et al.
Publicado: (2013)

Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
por: Jurczyk, Magdalena, et al.
Publicado: (2022)

Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation
por: Hu, Kaili, et al.
Publicado: (2012)

Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells
por: Hong, Jung Min, et al.
Publicado: (2014)

Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery
por: Tennvall, J, et al.
Publicado: (2002)

Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer
por: Lin, Bo, et al.
Publicado: (2020)

Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells
por: Zheng, Xu, et al.
Publicado: (2018)

Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects
por: Lin, Xiao-Min, et al.
Publicado: (2021)

Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma
por: Zhao, Hua-Dong, et al.
Publicado: (2016)

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
por: Zhang, Lili, et al.
Publicado: (2019)

Resveratrol-Loaded TPGS-Resveratrol-Solid Lipid Nanoparticles for Multidrug-Resistant Therapy of Breast Cancer: In Vivo and In Vitro Study
por: Wang, Wenrui, et al.
Publicado: (2021)

Resveratrol Reverses Retinoic Acid Resistance of Anaplastic Thyroid Cancer Cells via Demethylating CRABP2 Gene
por: Liu, Xin, et al.
Publicado: (2019)

Sodium orthovanadate inhibits growth and triggers apoptosis of human anaplastic thyroid carcinoma cells in vitro and in vivo
por: Yu, Qingan, et al.
Publicado: (2019)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
por: Saremi, Shahrooz, et al.
Publicado: (2011)

Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
por: Saremi, Shahrooz, et al.
Publicado: (2013)

In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines
por: Baldini, Enke, et al.
Publicado: (2022)

Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors
por: Gigliotti, Casimiro Luca, et al.
Publicado: (2017)

Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect
por: Noori Koopaei, Mona, et al.
Publicado: (2014)

Solid Lipid Nanoparticle Formulations of Docetaxel Prepared with High Melting Point Triglycerides: In Vitro and in Vivo Evaluation
por: Naguib, Youssef Wahib, et al.
Publicado: (2014)

Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex(®) nanoparticles for docetaxel delivery in ovarian cancer
por: Ghassami, Erfaneh, et al.
Publicado: (2018)

Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
por: Liu, Jia, et al.
Publicado: (2022)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)

Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment
por: Wu, Bo, et al.
Publicado: (2017)

OR21-03 Determining Novel Therapeutic Targets Using an in Vitro Model of TRb Tumor Suppression in Anaplastic Thyroid Cancer
por: Gillis, Noelle E, et al.
Publicado: (2020)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells
por: Lee, Sang-Han, et al.
Publicado: (2021)

Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors()
por: Guo, Xiong, et al.
Publicado: (2019)

Current Application of Nanoparticle Drug Delivery Systems to the Treatment of Anaplastic Thyroid Carcinomas
por: Wang, Chonggao, et al.
Publicado: (2023)

Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways
por: Park, Chan Ho, et al.
Publicado: (2018)

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f0nnms8c4sguf7ni8q3lb3q7ce